NYSE$ASPN

Aspen Aerogels Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Aspen Aerogels reported record revenue driven by PyroThin sales and improved gross profit margins in Q3 2023.

Aspen Aerogels reported record revenue of $60.8 million in Q3 2023, driven by a 160% quarter-over-quarter increase in PyroThin® revenues, reaching $32.8 million. The company's gross profit margins improved to 23%, a 6-percentage point increase from the previous quarter. Net loss was $13.1 million, and adjusted EBITDA was $(7.3) million, showing improvements compared to the previous year.

  • Record quarterly revenues reached $60.8 million.
  • PyroThin thermal barrier revenues were $32.8 million, up 160% quarter-over-quarter.
  • Gross profit margins improved to 23%.
  • Cash and equivalents ended the quarter at $94.6 million.

Headline financials

Total Revenue

$60.8M

Previous: $36.7M+65.5%
EPS (adj)

-$0.19

Previous: -$0.75+74.7%
Capital Expenditures

-$148M

Previous: -$119M-23.7%
Free Cash Flow

-$161M

Previous: -$149M-7.9%
Net Income

-$13.1M

Previous: -$29.6M+55.8%
Operating Income

-$14.6M

Previous: -$28.3M+48.3%
Gross Profit

$13.8M

Previous: -$6.36M+317.2%
Cash & Equivalents

$94.6M

Previous: $102M-7.6%
Total Assets

$605M

Previous: $385M+57.0%
R&D Expense

$4.22M

No prior period

Revenue & EPS history

Aspen Aerogels · Revenue · Quarterly

$60.8M

Q3 2023+65.5%vs Q3 2022
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Aspen Aerogels · $125M total across 1 segment · Q4 2022

  • Energy Industrial
    $125M

Forward guidance

Aspen updated its 2023 full year outlook. Total revenue is expected to be greater than $225.0 million. Net loss is expected to range between $62.4 million and $52.4 million. Adjusted EBITDA is expected to range between $(40.0) million and $(30.0) million. Net loss per share is expected to range between $0.90 and $0.76 Capital Expenditures are expected to be up to $175 million.

Tailwinds

  • Total revenue is expected to be greater than $225.0 million.
  • Net loss is expected to range between $62.4 million and $52.4 million.
  • Adjusted EBITDA is expected to range between $(40.0) million and $(30.0) million.
  • Net loss per share is expected to range between $0.90 and $0.76
  • Capital Expenditures are expected to be up to $175 million.

Headwinds

  • Additional charges
  • Realize gains or losses
  • Incur financing costs or interest expense
  • Experience other events in 2023, including those related to the planned capacity expansion
  • Supply chain disruptions or further cost inflation, that could cause actual results to vary materially from this outlook.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+0.3%

Avg return

Earnings day

+3.6%

Avg return

5 days after

+3.3%

Avg return

30 days after

57%

29 / 51 earnings

Positive

+52.3%

Q1 2024

Best reaction

-44.7%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.8%+5.3%+9.9%
Q4 2025-26.7%-7.9%-7.3%
Q3 2025-44.7%-51.1%-52.2%
Q1 2025-24.3%+4.4%+5.8%
Q4 2024-23.4%-27.3%-37.2%
Q3 2024-9.4%-6.8%-27.8%
Q2 2024+8.8%+16.8%+20.5%
Q1 2024+52.3%+65.4%+91.1%
Q4 2023+19.4%+46.3%+49.2%
Q3 2023+11.1%+16.6%+43.4%
Q2 2023-8.7%-14.4%-22.2%
Q1 2023+22.5%+30.6%+19.9%
Q4 2022+16.5%+12.1%-37.9%
Q3 2022+6.7%+18.9%+24.4%
Q2 2022+19.9%+28.7%+29.3%
Q1 2022-5.5%-5.7%-21.3%
Q4 2021+3.8%-0.5%+12.0%
Q3 2021+16.3%+12.4%+23.5%
Q2 2021-4.4%-4.0%+12.1%
Q1 2021-11.8%-13.7%-1.8%
Q4 2020-1.1%-1.0%-16.3%
Q3 2020+6.8%+8.4%+41.0%
Q2 2020+1.0%-3.8%+41.8%
Q1 2020+5.7%+17.8%+8.0%
Q4 2019-2.5%-18.1%-48.2%
Q3 2019+13.2%+11.5%+15.0%
Q2 2019-5.0%-2.0%-8.5%
Q1 2019+6.0%+9.3%+16.7%
Q4 2018+2.5%+5.1%-19.2%
Q3 2018+10.3%+10.6%-6.1%
Q2 2018-7.5%-8.7%-6.6%
Q1 2018+1.8%+5.4%+13.0%
Q4 2017+2.3%+1.8%-4.1%
Q3 2017+7.4%+9.0%+8.5%
Q2 2017+6.1%+4.2%-8.6%
Q1 2017+4.5%+9.2%+6.7%
Q4 2016-7.8%-4.8%-7.6%
Q3 2016-33.1%-34.8%-32.3%
Q2 2016-4.8%-3.2%+2.4%
Q1 2016+4.2%
Q4 2015+9.9%
Q3 2015-20.8%
Q2 2015+7.4%
Q1 2015-4.5%
Q4 2012-10.3%
Q1 2013-10.3%
Q3 2013-16.2%
Q4 2014+13.6%
Q2 2013+9.2%
Q4 2013+9.2%
Q2 2014+0.4%
Q3 2014
Q1 2014
Q3 2012
Q2 2011
Q1 2011
Q2 2010
Q1 2010

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro